BioEcho has developed a novel product reflecting the company belief that even the most routine molecular biology protocols can be improved: the EchoLUTION Cell Culture RNA Kit. The product delivers dedicated solutions to customers committed with expanding fields such as drug discovery, sequencing, and basic research, such as oncology, immunology, and transcriptomics.

“The single step process innovates the isolation of high-quality RNA out of cells for various applications, reduces the time to result for researchers and saves a lot of hands-on time without making compromises in quality. Further it supports the ESG (Environmental, Social, and Governance) initiatives by reducing plastics, solvents, and using reusable components”, states Dr. Thomas Neumann, Chief Commercial Officer at BioEcho.

The EchoLUTION Cell Culture RNA Kit is a most convenient and reliable kit that is easy to integrate, as only standard laboratory equipment is needed. It is based on an ultra-fast lysis combined with the EchoLUTION technology, which enables total RNA extraction from different cell types (fresh, frozen, and stabilized; adherent or suspension cells) in just one single step. This innovative technology makes the purification 50 – 70 % faster than established kits on the market based on the bind-wash-elute procedure.

The result is a premium-quality RNA with superior integrity (RIN: 9 – 10) and competitive yield in comparison to silica-based methods. Further, EchoLUTION technology avoids inhibitory reagents (e.g., EtOH) in the final product, which provides an RNA sample perfectly suited for downstream applications such as RT-PCR, RT-qPCR, and RNAseq. As other BioEcho products, the EchoLUTION Cell Culture RNA Kit reduced hazardous reagents to minimum and decreases the associated plastic consumption to 60 %.

For more information about EchoLUTION Cell Culture RNA Kit and workflow, please visit www.bioecho.com/Cell-RNA or contact BioEcho via email at contact@bioecho.de

 

Über die BioEcho Life Sciences GmbH

BioEcho Life Sciences is a specialized solution provider for the extraction and analysis of nucleic acids. We create disruptive technologies, products, and workflows that make downstream processing of nucleic acids easier and faster, significantly increase throughput, and deliver reliable results. Our EchoLUTION technology enables the fastest DNA and RNA extraction on the market – in just one single step – and drastically reduces the associated plastic consumption.

BioEcho, headquartered in Cologne, Germany, was founded in 2016 by leading industry experts. The headquarter is certified according to ISO 9001 and ISO 13485.

BioEcho. The Nucleic Acid Experts.

www.bioecho.com

Firmenkontakt und Herausgeber der Meldung:

BioEcho Life Sciences GmbH
Nattermannallee 1
50829 Köln
Telefon: +49 221 998897 0
http://www.bioecho.de/

Ansprechpartner:
Dr Laura Torres Benito
Scientific Communications Manager
Telefon: +49 221 998897-24
E-Mail: laura.torres.benito@bioecho.de
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel